Microbot Medical Inc (MBOT)
Official siteHEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • NASDAQ
Market Cap: $65.73M
Last updated: Nov 17, 2026 at 11:05 AM ET
Microbot Medical Inc (MBOT) Stock Forecast
Analysts expect Microbot Medical (MBOT) to earn -$0.31 per share in the fiscal year ending Dec 31, 2026, on revenue of $1.27M. Of 3 analysts, 3 rate the stock Buy or Strong Buy, 0 Hold and 0 Sell or Strong Sell, for a consensus of Buy. Over the last 30 days, 1 estimate for the fiscal year ending Dec 31, 2026 was revised up and 1 down.
Analyst Ratings
Scoring Strong Buy as 1 and Strong Sell as 5, the 3 ratings average 2.00, inside the Buy band from 1.5 up to 2.5. Buy and Strong Buy make up 100% of the ratings.
| Rating | Analysts | Share |
|---|---|---|
| Strong Buy | 0 | 0.0% |
| Buy | 3 | 100.0% |
| Hold | 0 | 0.0% |
| Sell | 0 | 0.0% |
| Strong Sell | 0 | 0.0% |
- Consensus
- Buy
- Total analysts
- 3
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus shows a larger loss and revenue estimates rise 379.5%.
- Fiscal year ending Dec 31, 2026
- -$0.31
- EPS consensus, revenue $1.27M
- Fiscal year ending Dec 31, 2027
- -$0.32
- EPS consensus, revenue $6.09M
- Next report
- Mar 24, 2027
- Estimated
EPS range
Revenue range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | -$0.31 | -$0.32 to -$0.29 | 4 | $1.27M | $896000 to $1.90M | 4 |
| Dec 31, 2027 | -$0.32 | -$0.37 to -$0.26 | 4 | $6.09M | $2.25M to $9.60M | 4 |
Quarterly Estimates
| Quarter ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | -$0.08 | -$0.09 to -$0.08 | 6 | $918000 | $294000 to $2.00M | 6 |
Estimate Revisions
Across the 2 periods below, the last 30 days brought 1 upward and 3 downward EPS revisions.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2026 | 1 | 1 |
| Fiscal year ending Dec 31, 2027 | 0 | 2 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has worsened from -$0.28.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | -$0.31 | -$0.30 | -$0.30 | -$0.31 | -$0.28 | N/A |
| Fiscal year ending Dec 31, 2027 | -$0.32 | -$0.31 | -$0.30 | -$0.34 | -$0.30 | N/A |
Frequently Asked Questions About MBOT
What is the MBOT stock forecast?
Consensus analyst estimates put Microbot Medical's EPS at -$0.31 for the fiscal year ending Dec 31, 2026, on revenue of $1.27M. The consensus rating from 3 analysts is Buy.
How do analysts rate MBOT stock?
Of 3 analysts covering Microbot Medical, 0 rate it Strong Buy, 3 Buy, 0 Hold, 0 Sell and 0 Strong Sell, for a consensus of Buy.
What EPS do analysts expect from MBOT next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is -$0.31, with estimates from -$0.32 to -$0.29 from 4 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is -$0.32, with estimates from -$0.37 to -$0.26 from 4 analysts.
What revenue do analysts expect from Microbot Medical next year?
For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $1.27M, with estimates from $896000 to $1.90M. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $6.09M, with estimates from $2.25M to $9.60M.
How many analysts cover MBOT?
3 analysts rate Microbot Medical stock, and 4 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.
MBOT pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors